Clinical

Dataset Information

High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM


ABSTRACT: This pilot phase I trial aims to investigate the efficacy and safety of high- and low-dose radiotherapy combined with programmed cell death-1 (PD-1) inhibitors in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) that have failed second-line immunotherapy or above.

DISEASE(S): Neoplasm Metastasis,Colorectal Liver Metastases

PROVIDER: 92574 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR